Common Contracts
1 similar Risk-Sharing Agreement contracts
The VASCADE® Vascular Closure System Performance Guarantee Risk-Sharing Agreement: Low Prevalence of Closure-Related ComplicationsRisk-Sharing Agreement • September 1st, 2020
Abstract: Objective: The National Cardiovascular Data Registry indicates bleeding complications occur among 5.8% of patients undergoing percutaneous coronary intervention (2008–2011); however, trials have demonstrated that the VASCADE® Vascular Closure System (VCS) lowers rates of access site closure–related complications. With an estimat- ed cost of $5,440 per bleeding complication, reducing complications may lead to substantial cost savings. By connecting quality metrics to costs, risk-sharing agreements (RSAs) can improve outcomes and patient satisfaction while managing financial risk. Here, we describe real-world experience and practical implications of femoral arterial vascular closure using the VCS by examining qualifying complications from participating institutions enrolled in a novel RSA, the Performance Guarantee (PG) partnership, reported during 2016–2020.
